News Focus
News Focus
icon url

acgood

12/02/10 10:17 AM

#109738 RE: dewophile #109732

Right. If teva's product is luponox, it wold seem less likely that that characterization patents are infringed-because if teva analyzed luponox with MNTAs technology methods, it would show it was clearly not the same product as lovenox